• Search

AAA to hear biotech claim against Japanese drugmaker

Sebastian Perry

13 November 2019

A US biotech company has filed a claim with the American Arbitration Association against Daiichi Sankyo over the ownership of technology the Japanese group is using in a drug candidate to treat breast cancer.